191 related articles for article (PubMed ID: 37534664)
1. [Globular placenta with infarction: A case report].
Li TY; Zhang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):758-761. PubMed ID: 37534664
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries.
Viero S; Chaddha V; Alkazaleh F; Simchen MJ; Malik A; Kelly E; Windrim R; Kingdom JC
Placenta; 2004; 25(8-9):735-41. PubMed ID: 15450392
[TBL] [Abstract][Full Text] [Related]
3. Placental glucose transporter 1 and 3 gene expression in Monochorionic twin pregnancies with selective fetal growth restriction.
Chang YL; Chao AS; Chang SD; Cheng PJ
BMC Pregnancy Childbirth; 2021 Mar; 21(1):260. PubMed ID: 33773574
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of placental-derived fetal growth restriction.
Burton GJ; Jauniaux E
Am J Obstet Gynecol; 2018 Feb; 218(2S):S745-S761. PubMed ID: 29422210
[TBL] [Abstract][Full Text] [Related]
5. Umbilical artery pulsatility index and half-peak systolic velocity deceleration time in fetuses with trisomy 21.
Bustos JC; Herrera A; Sepulveda W
J Matern Fetal Neonatal Med; 2020 Oct; 33(20):3469-3475. PubMed ID: 30741044
[No Abstract] [Full Text] [Related]
6. Evaluation of normalization of cerebro-placental ratio as a potential predictor for adverse outcome in SGA fetuses.
Monteith C; Flood K; Mullers S; Unterscheider J; Breathnach F; Daly S; Geary MP; Kennelly MM; McAuliffe FM; O'Donoghue K; Hunter A; Morrison JJ; Burke G; Dicker P; Tully EC; Malone FD
Am J Obstet Gynecol; 2017 Mar; 216(3):285.e1-285.e6. PubMed ID: 27840142
[TBL] [Abstract][Full Text] [Related]
7. A placenta clinic approach to the diagnosis and management of fetal growth restriction.
Kingdom JC; Audette MC; Hobson SR; Windrim RC; Morgen E
Am J Obstet Gynecol; 2018 Feb; 218(2S):S803-S817. PubMed ID: 29254754
[TBL] [Abstract][Full Text] [Related]
8. The hemodynamics of late-onset intrauterine growth restriction by MRI.
Zhu MY; Milligan N; Keating S; Windrim R; Keunen J; Thakur V; Ohman A; Portnoy S; Sled JG; Kelly E; Yoo SJ; Gross-Wortmann L; Jaeggi E; Macgowan CK; Kingdom JC; Seed M
Am J Obstet Gynecol; 2016 Mar; 214(3):367.e1-367.e17. PubMed ID: 26475425
[TBL] [Abstract][Full Text] [Related]
9. The impact of placental massive perivillous fibrin deposition on neonatal outcome in pregnancies complicated by fetal growth restriction.
Spinillo A; Gardella B; Muscettola G; Cesari S; Fiandrino G; Tzialla C
Placenta; 2019 Nov; 87():46-52. PubMed ID: 31546153
[TBL] [Abstract][Full Text] [Related]
10. Maternal plasma syndecan-1: a biomarker for fetal growth restriction.
Juusela A; Jung E; Gallo DM; Bosco M; Suksai M; Diaz-Primera R; Tarca AL; Than NG; Gotsch F; Romero R; Chaiworapongsa T
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2150074. PubMed ID: 36597808
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms.
Macara L; Kingdom JC; Kaufmann P; Kohnen G; Hair J; More IA; Lyall F; Greer IA
Placenta; 1996 Jan; 17(1):37-48. PubMed ID: 8710812
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of placental neuropilin-1 in fetal growth restriction.
Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
[TBL] [Abstract][Full Text] [Related]
13. Sustained hematological consequences in the first week of neonatal life secondary to placental dysfunction.
Kush ML; Gortner L; Harman CR; Baschat AA
Early Hum Dev; 2006 Jan; 82(1):67-72. PubMed ID: 16198513
[TBL] [Abstract][Full Text] [Related]
14. Maternal vascular malformation in the placenta is an indicator for fetal growth restriction irrespective of neonatal birthweight.
Hendrix MLE; Bons JAP; Alers NO; Severens-Rijvers CAH; Spaanderman MEA; Al-Nasiry S
Placenta; 2019 Nov; 87():8-15. PubMed ID: 31520871
[TBL] [Abstract][Full Text] [Related]
15. Doppler evaluation of normal and abnormal placenta.
Hernandez-Andrade E; Huntley ES; Bartal MF; Soto-Torres EE; Tirosh D; Jaiman S; Johnson A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):28-41. PubMed ID: 34806234
[TBL] [Abstract][Full Text] [Related]
16. Placental MRI in intrauterine fetal growth restriction.
Damodaram M; Story L; Eixarch E; Patel A; McGuinness A; Allsop J; Wyatt-Ashmead J; Kumar S; Rutherford M
Placenta; 2010 Jun; 31(6):491-8. PubMed ID: 20347139
[TBL] [Abstract][Full Text] [Related]
17. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.
Kennedy LM; Tong S; Robinson AJ; Hiscock RJ; Hui L; Dane KM; Middleton AL; Walker SP; MacDonald TM
BMC Med; 2020 Dec; 18(1):395. PubMed ID: 33357243
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and surveillance of late-onset fetal growth restriction.
Figueras F; Caradeux J; Crispi F; Eixarch E; Peguero A; Gratacos E
Am J Obstet Gynecol; 2018 Feb; 218(2S):S790-S802.e1. PubMed ID: 29422212
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation.
Aurioles-Garibay A; Hernandez-Andrade E; Romero R; Qureshi F; Ahn H; Jacques SM; Garcia M; Yeo L; Hassan SS
Fetal Diagn Ther; 2014; 36(2):154-61. PubMed ID: 24852332
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.
McCowan LM; Figueras F; Anderson NH
Am J Obstet Gynecol; 2018 Feb; 218(2S):S855-S868. PubMed ID: 29422214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
